Current advances in anti-influenza therapy

Current Medicinal Chemistry

Volumn 17, Issue 20, 2010, Pages 2101-2140

  Saladino, R ^a   Barontini, M ^a   Crucianelli, M ^b   Nencioni, L ^c   Sgarbanti, R ^c   Palamara, A T ^d,e  

^a UNIVERSITY OF TUSCIA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Pasteur Institute   (Italy)

^e IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Antiviral compounds; Biological activity; Influenza therapy; Synthesis

Indexed keywords

2 AMINO 5' DEOXY 5' FLUOROADENOSINE; 5 AZOLYLTHIOPYRIMIDINE; ACYL(THIO)UREA AND 2H 1,2,4 THIADIAZOLO [2,3 A] PYRIDINE; AMANTADINE; ANTIVIRUS AGENT; ARBIDOL; ARENAROL; AUREOL; CATECHIN; CYCLOHEXANE; CYCLOHEXENE DERIVATIVE; CYCLOPENTAMINE; FAVIPIRAVIR; FLAVANOID; FLUTIMIDE; HETEROCYCLOHEXENE; OSELTAMIVIR; PERAMIVIR; POLYPHENOL DERIVATIVE; PYRAZINE; PYRROLIDINE DERIVATIVE; RESVERATROL; RIBAVIRIN; RIMANTADINE; SIALIC ACID; STACHYFLIN; TERPENOID; TRIPERIDENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZANAMIVIR; ADAMANTANE; CYCLOHEXENE; CYCLOPENTANE DERIVATIVE; FLAVONOID; GLUTATHIONE; HETEROCYCLIC COMPOUND; PHENOL DERIVATIVE; POLYPHENOL;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL BUDDING; CELL MATURATION; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SYNTHESIS; ENDOSOME; HUMAN; INFLUENZA; NONHUMAN; PROGENY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TREATMENT OUTCOME; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; ANALOGS AND DERIVATIVES; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; INFLUENZA, HUMAN; ORTHOMYXOVIRUS;

ADAMANTANE; ANTIVIRAL AGENTS; CYCLOHEXENES; CYCLOPENTANES; FLAVONOIDS; GLUTATHIONE; HETEROCYCLIC COMPOUNDS; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; PHENOLS; POLYPHENOLS;

EID: 77955624119     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791299957     Document Type: Article

References (194)

1. Palese, P.; Shaw, M.L. In Virology; Fields, B.N.; Knipe, D.M.; Howley, P.M. Ed.; Lippincott-Raven Publishers: Philadelphia, 2007; Vol. 47, pp. 1647-1689.
2. Neumann, G.; Noda, T.; Kawaoka, Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature, 2009, 459, 931-939.
3. Dawood, F.S.; Jain, S.; Finelli, L. Emergence of a novel Swine-origin influenza A(H1N1) virus in humains. NEJM, 2009, 360, 2605-2615.
4. Garten, R.J.; Davis, C.T.; Russell, C.A.; Shu, B.; Lindstrom, S.; Balish, A.; Session, W.M. Antigenic and genetic characteristics of Swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 2009, 325, 197-201.
5. Smith, G.J.; Vijakrishna, D.; Bahl, J.; Lycett, S.J.; Worobey, M.; Pybus, O.G.; Ma, S.K.; Cheung, L.L.; Raghwani, J.; Bhatt, S.; Peris, A. Origins and evolutionary genomics of the 2009 Swineorigin H1N1 influenza A epidemic. Nature, 2009, 459, 1122-1115.
6. Itoh, Y.; Shinya, K.; Kiso, M.; Watanabe, T.; Sakoda, Y.; Hatta, M.; Muramoto, Y.; Tamura, D.; Sakai-Tagawa, Y.; Noda, T.; Sakabe, S.; Imai, M.; Hatta, Y.; Watanabe, S.; Li, C.; Yamada, S.; Fujii, K.; Murakami, S.; Imai, H.; Kakugawa, S.; Ito, M.; Takano, R.; Iwatsuki-Horimoto, K.; Shimojima, M.; Horimoto, T.; Goto, H.; Takahashi, K.; Makino, A.; Ishigaki, H.; Nakayama, M.; Okamatsu, M.; Takahashi, K.; Warshauer, D.; Shult, P.A.; Saito, R.; Suzuki, H.; Furuta, Y.; Yamashita, M.; Mitamura, K.; Nakano, K.; Nakamura, M.; Brockman-Schneider, R.; Mitamura, H.; Yamazaki, M.; Sugaya, N.; Suresh, M.; Ozawa, M.; Neumann, G.; Gern, J.; Kida, H.; Ogasawara, K.; Kawaoka, Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature, 2009, 460, 1021-1025.
7. Palese, P.; Shaw, M.L. In Virology; Fields, B.N., Knipe, D.M., Howley, P.M. Ed.; Lippincott-Raven Publishers: Philadelphia, 2007; Vol. 47, pp. 1647-1689.
8. Chen, W.; Calvo, P.A.; Malide, D.; Gibbs, J.; Schubert, U.; Bacik, I.; Basta, S.; O'Neill, R.; Schickli, J.; Palese, P.; Henklein, P.; Bennink, J.R.; Yewdell, J.W. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med., 2001, 7 (12), 1306-1312.
9. Cros, J.F.; Palese, P. Trafficking of viral genomic RNA into and out of the nucleus: Influenza, Thogoto and Borna disease viruses. Virus Res., 2003, 95, 3-12.
10. Bui, M.; Wills, E.G.; Helenius, A.; Whittaker, G.R. Role of the Influenza Virus M1 Protein in Nuclear Export of Viral Ribonucleoproteins. J. Virol., 2000, 74, 1781-1786.
11. Pleschka, S.; Wolff, T.; Ehrhardt, C.; Hobom, G.; Planz, O.; Rapp, U.R. Ludwig, S. Influenza virus propagation is impaired by inhibition of the RAF/ MEK/ERK signaling cascade. Nat. Cell Biol., 2001, 3, 301-305.
12. Nencioni, L.; Iuvara, A.; Aquilano, K.; Ciriolo, M.R.; Cozzolino, F.; Rotilio, G.; Garaci, E.; Palamara, A.T. Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2. FASEB J., 2003, 17, 758-760.
13. Palamara, A.T.; Nencioni, L.; Aquilano, K.; De Chiara, G.; Hernandez, L.; Cozzolino, F.; Ciriolo, M.R.; Garaci, E. Inhibition of Influenza A Virus Replication by Resveratrol. J. Infect. Dis., 2005, 191, 1719-1729.
14. Shin, Y.K.; Li, K.; Liu, Q.; Anderson, D.H.; Babiuk, L.A.; Zhou, Y. SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J. Virol., 2007, 81, 12730-12739.
15. Nencioni, L.; De Chiara, G.; Sgarbanti, R.; Amatore, D.; Aquilano, K.; Marcocci, M.E.; Serafino, A.; Torcia, M.; Cozzolino, F.; Ciriolo, M.R.; Garaci, E.; Palamara, A.T. Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication. J. Biol. Chem., 2009, 284 (23), 16004-16015.
16. Fraternale, A.; Paoletti, M.F.; Casabianca, A.; Oiry, J.; Clayette, P.; Vogel, J.U.; Cynatl, J.Jr.; Palamara, A.T.; Sgarbanti, R.; Garaci, E.; Millo, E.; Benfatti, U.; Magnani, M. Antiviral and immunomodulatory properties of new pro-glutathione (GSH) molecules. Curr. Med. Chem., 2006, 13, 1749-1755.
17. Akhand, A.A.; Du, J.; Liu, W.; Hossain, K.; Miyata, T.; Nagase, F.; Kato, M.; Suzuki, H.; Nakashima, I. Redox-linked cell surfaceoriented signaling for T-cell death. Antioxidants Redox Signal., 2002, 4, 445-454.
18. Nakamura, H.; Nakamura, K.; Yodoi, J. Redox regulation of cellular activation. Annu. Rev. Immunol., 1997, 15, 351-369.
19. Lagoja, I.M.; De Clercq, E. Anti-InluenzaVirus Agents: Synthesis and Mode of Action. Med. Res. Rev., 2008, 28, 1-38.
20. Roberts, NA.; Anti-influenza drugs and neuraminidase inhibitors. Prog. Drug Res 2001, 56, 195-237.
21. Shigeta, S. Targets of antiinfluenza chemotherapy other than neuraminidase and proton pump. Antiviral Chem Chemother., 2001, 12, 179-188.
22. Schmidt, AC. Antiviral therapy for influenza. A clinical and economic comparative review. Drugs, 2004, 64(18), 2031-2046.
23. Monto, A.S. The role of antivirals in the control of influenza. Vaccine, 2003, 21, 1796-1800.
24. De Clercq, E. Highlights in the development of new antiviral agents. Mini Rev. Med. Chem., 2002, 2, 163-175.
25. Ison, M.G.; Hayden, F.G. Therapeutic options for the management of influenza. Curr. Opin. Pharmacol., 2001, 1, 482-490.
26. Kandel, R; Hartshorn, K.L. Prophylaxis and treatment of influenza virus infection. BioDrugs, 2001, 15(3), 303-323.
27. Tashiro, M.; Klenk, H.D.; Rott, R. Inhibitory effect of a protease inhibitor, leupeptin, on the development of influenza pneumonia, mediated by concomitant bacteria. J. Gen. Virol., 1987, 68 (Pt 7), 2039-2041.
28. Nencioni, L.; De Chiara, G.; Sgarbanti, R.; Amatore, D.; Aquilano, K.; Marcocci, M.E.; Serafino, A.; Torcia, M.; Cozzolino, F.; Ciriolo, M.R.; Garaci, E.; Palamara, A.T. Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication. J. Biol. Chem., 2009, 284(23), 16004-16015.
29. Beigel, J.; Bray, M. Current and future antiviral therapy of severe seasonal and avian influenza. Antivir. Res., 2008, 78, 91-102 and references cited therein.
30. De Clercq, E. Antiviral agents active against influenza A viruses. Nat. Rev. Drug Discov., 2006, 5, 1015-25.
31. Zoidis, G.; Fytas, C.; Papanastasiou, I.; Foscolos, G. B.; Fytas, G.; Padalko, E.; De Clercq, E.; Naesens, L.; Neyts, J.; Kolocouris, N. Heterocyclic rimantadine analogues with antiviral activity. Bioorg. Med. Chem., 2006, 14, 3341-48, and references cited therein.
32. Tataridis, D.; Fytas, G.; Kolocouris, A.; Fytas, C.; Kolocouris, N.; Foscolos, G. B.; Padalko, E.; Neyts, J.; De Clercq, E. Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A. Bioorg. Med. Chem. Lett., 2007, 17, 692-96.
33. Kelly, J. M.; Miles, M. A.; Skinner, A. C. The Anti-Influenza Virus Drug Rimantadine has Trypanocidal Activity. Antimicrob. Agents Chemother., 1999, 43, 985-87.
34. Papanastasiou, I.; Tsotinis, A.; Kolocouris, N.; Radhika Prathalingam S.; Kelly, J. M. Design, synthesis and trypanocidal activity of new aminoadamantane derivatives. J. Med. Chem., 2008, 51, 1496-1500.
35. Zoidis, G.; Tsotinis, A.; Kolocouris, N.; Kelly, J. M.; Radhika Prathalingam S.; Naesens, L.; De Clercq, E. Design and synthesis of bioactive 1,2-annulated adamantane derivatives. Org. Biomol. Chem., 2008, 6, 3177-85.
36. Stylianakis, I.; Kolocouris, A.; Kolocouris, N.; Fytas, G.; Foscolos, G. B.; Padalko, E.; Neyts, J.; De Clercq, E. Spiro[pyrrolidine-2,2;- adamantanes]: Synthesis, Anti-Influenza Virus Activity and Conformational Properties. Bioorg. Med. Chem. Lett., 2003, 13, 1699-1703.
37. Oka, M.; Ishiwata, Y.; Iwata, N.; Honda, N.; Kakigami, T. Synthesis and anti-influenza virus activity of tricyclic compounds with a unique amine moiety. Chem. Pharm. Bull., 2001, 49, 379-83.
38. Rybalko, S.; Nesterova, N.; Diadiun, S.; Danylenko, G.; Danylenko, V.; Guzhova, S.; Maksimov, Y.; Arkadiev, V.; Ivans'ka, N.; Maksymenok, O.; Vrnycianu, N.; Zhtrebtsova, E.; Grygoreva, T. Therapeutical effect of modified adamantane copolymer compounds: Study of molecular mechanisms. Acta Biochim. Pol., 2001, 48, 241-249.
39. For recent reviews on the biological activities of natural tetracyclic core derivatives see: De Rosa, S.: Natural Products in the New Millennium: Prospects and Industrial Application. Rauter, A. P., Palm, F. B., Justino, J., Araujo, M. E., dos Santos, S. P., Eds.; Kluwer Academic Publishers: The Netherlands, 2002; pp. 441-461.
40. For the evaluation of the anti-influenza activity of Stachyflin see: Minagawa, K.; Kouzuki, S.; Yoshimoto, J.; Kawamura, Y.; Tani, H.; Iwata, T.; Terui, Y.; Nakai, H.; Yagi, S.; Hattori, N.; Fujiwara, T. and Kamigauchi, T.: Stachyflin and acetylstachyflin, novel antiinfluenza A virus substances, produced by Stachybotrys sp RF- 7260 I. Isolation, structure elucidation and biological activities. J. Antibiot., 2002, 55(2) 155-164.
41. Yoshimoto, J.; Kakui, M.; Iwasaki, H.; Sugimoto, H.; Fujiwara, T.; and Hattori, N.: Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, stachyflin. Microbiol. Immunol., 2000, 44(8) 677-685.
42. Nakatani, M.; Nakamura, M.; Suzuki, A.; Inoue, M.; Katoh, T.: A new strategy toward the total synthesis of Stachyflin, a potent antiinfluenza A virus agent: concise route to the tetracyclic core structure. Org. Lett., 2002, 4, 4483-4486.
43. See also: Sakurai, J.; Oguchi, T.; Watanabe, K.; Abe, H.; Kanno, S.; Ishikawa, M.; Katoh, T.: Highly efficient total synthesis of the marine natural products (+)- avarone, (+)-avarol, (-)-neoavarone, (-)- neoavarol and (+)-aureol. Chem. Eur. J., 2008, 14, 829-837.
44. Nakatani, M.; Suzuki, A.; Nakatani, M.; Fuchikami, T.; Inoue, M.; Katoh, T. An efficient synthesis of (+)-aureol via boron trifluoride etherate-promoted rearrangement of (+)-arenarol. Tetrahedron Lett., 2002, 43, 6929-6932.
45. Matsuya, Y.; Sasaki, K.; Ochiai, H.; Nemoto, H.: Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic. Bioorg. Med. Chem., 2007, 15, 424-432.
46. Babu, Y.S.; Chand, P.; Bantia, S.; Kotian, P.; Dehghani, A.; El-Kattan, Y.; Lin, T.H.; Hutchison, T.L.; Elliott, A.J.; Parker, C.D.; Ananth, S.L.; Horn, L.L.; Laver, G.W. and Montgomery, J.A.: BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design J. Med. Chem., 2000, 43, 3482-3486.
47. Bantia, S.; Arnold, C.S.; Parker, C.D.; Upshaw, R.; Chand, P.: Anti-influenza virus activity of peramivir in mice with single intramuscular injection. Antiviral Res., 2006, 69, 39-45.
48. Prepared as reported in: Zhang, D.; Siiling, C.; Miller, M.J.: The Hetero Diels-Alder Reactions between d-Mannose-Derived Halonitroso Compounds and Cyclopentadiene: Scope and Limitations. J. Org. Chem., 1998, 63, 885-888.
49. Mineo, T.; Miller, M.: Stereoselective total synthesis of racemic BCX-1812 (RWJ-270201) for the development of neuraminidase inhibitors as anti-influenza agents. J. Org. Chem., 2003, 68 (17), 6591-6596.
50. See for example: Raja, S.N.; George, K.S.; Fan, L.; Nequist, G.; Reisch, T.; Maring, C.; Mc Daniel, K.; De Goey, D.; Darbyshire, K.: Abstracts of Papers, 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago (IL); Am. Soc. Microb., Washington DC, 2001.
51. De Goey, D.A.; Chen, H.J.; Flosi, W.J.; Grampovnik, D.J.; Yeung, C.M.; Klein, L.L.; Kempf, D.: Enantioselective synthesis of antiinfluenza compound A-315675. J. Org. Chem., 2002, 67, 5445-5453.
52. Kati, W.M.; Montgomery, W.; Norbeck, D.W.: Novel a- and baminoacid inhibitors of influenza virus neuraminidase. Antimicrobial Agents Chemother., 2001, 45, 2563-2570.
53. Honda, T.; Masuda, T.; Yoshida, S.; Arai, M.; Kobayashi, Y.; Yamashita, M. Synthesis and anti-influenza virus activity of 4- guanidino-7-substituted Neu5Ac2en derivatives. Bioorg. Med. Chem. Lett., 2002, 12, 1921-24.
54. Honda, T.; Masuda, T.; Yoshida, S.; Arai, M.; Kaneko, S.; Yamashita, M. Synthesis and anti-influenza virus activity of 7-Oalkylated derivatives related to zanamivir. Bioorg. Med. Chem. Lett., 2002, 12, 1925-28.
55. Masuda, T.; Yoshida, S.; Arai, M.; Kaneko, S.; Yamashita, M.; Honda, T. Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives. Chem. Pharm. Bull., 2003, 51, 1386-98.
56. Liu, Z.Y.; Wang, B.; Zhao, L.X.; Li, Y.H.; Shao, H.Y.; Yi, H.; You, X.F.; Li, Z.R. Synthesis and anti-influenza activities of carboxylalkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir). Bioorg. Med. Chem. Lett., 2007, 17, 4851-54.
57. Masuda, T.; Shibuya, S.; Arai, M.; Yoshida, S.; Tomozawa, T.; Ohno, A.; Yamashita, M.; Honda, T. Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir. Bioorg. Med. Chem. Lett., 2003, 13, 669-73.
58. Macdonald, S. J. F.; Cameron, R.; Demaine, D. A.; Fenton, R. J.; Foster, G.; Gower, D.; Hamblin, J. N.; Hamilton, S.; Hart, G. J.; Hill, A. P.; Inglis, G. G. A.; Jin, B.; Jones, H. T.; McConnell, D. B.; McKimm-Breschkin, J.; Mills, G.; Nguyen, V.; Owens, I. J.; Parry, N.; Shanahan, S. E.; Smith, D.; Watson, K. G.; Wu, W.-Y.; Tucker, S. P. Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza. J. Med. Chem., 2005, 48, 2964-71.
59. Lu, Y.; Gervay-Hague, J. Synthesis of C-4 and C-7 triazole analogs of zanamivir as multivalent sialic acid containing scaffolds. Carbohydr. Res., 2007, 342, 1636-50.
60. Mann, M. C.; Islam, T.; Dyason, J. C.; Florio, P.; Trower, C. J.; Thomson, R. J.; von Itzstein, M. Unsaturated N-acetyl-Dglucosaminuronic acid glycosides as inhibitors of influenza virus sialidase. Glycoconj. J. 2006, 23, 127-33.
61. Ono, H.; Nagano, Y.; Matsunami, N.; Sugiyama, S.; Yamamoto, S.; Tanabe, M. Oseltamivir, an anti-influenza virus drug, produces hypothermia in mice: Comparison among oseltamivir, zanamivir and diclofenac. Biol. Pharm. Bull., 2008, 31, 638-42.
62. Shibasaki, M.; Kanai, M. Synthetic strategies for oseltamivir phosphate. Eur. J. Org. Chem., 2008, 1839-50.
63. Karpf, M.; Trussardi, R. New, Azide-Free Transformation of epoxides into 1,2-diamino. compounds: Synthesis of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu). J. Org. Chem., 2001, 66, 2044-51.
64. Yeung, Y.-Y.; Hong, S.; Corey, E. J. A Short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid. J. Am. Chem. Soc., 2006, 128, 6310-6311.
65. Yamatsugu, K.; Kamijo, S.; Suto, Y.; Kanai, M.; Shibasaki, M. A concise synthesis of Tamiflu: third generation route via the Diels- Alder reaction and the Curtius rearrangement. Tetrahedron Lett., 2007, 48, 1403-1406.
66. Shie, J.J.; Fang, J.M.; Wang, S.Y.; Tsai, K.C.; Cheng, Y.S. E.; Yang, A.S.; Hsiao, S.C.; Su, C.Y.; Wong, C.H. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. J. Am. Chem. Soc., 2007, 129, 11892-11893.
67. Wong, C.H.; Fang, J.M.; Shie, J.J.; Cheng, Y.S. E.; Jan, J.T. Synthesis of Oseltamivir Containing Phosphonate Congeners with Anti- Influenza Activity. WO Patent, 2009, 029888.
68. Page, T.; Connor, J.D. The metabolismo f ribavirin in erythrocytes and nucleated cells. Int. J. Biochem., 1990, 22(4), 379-383.
69. Tsai, S.L.; Liaw, Y.F.; Chen, M.H.; Huang, C.Y.; Kuo, G.C.: Detection of type 2-like T-helper cells in hepatitis C virus infection: implicitions for hepatitis C virus chronicity. Hepatology, 1997, 25(2), 449-458.
70. Kentsis, A.; Topisirovic, I.; Culjkovic, B.; Shao, L.: Borden transformation by physical mimicry of the 7-methylguanosine mRNA cap. Proc. Natl. Acad. USA, 2004, 101(52), 18105-18110.
71. Vo, N.V.; Yong, K.C., Lai, M.M. Mutagenic and inhibitory effect of ribavirin on hepatitis C virus RNA polymerase. Biochemistry, 2003, 42(35), 10462-10471.
72. Zhou, S.; Liu, R.; Barandy, B.M.; Malcom, B.A.; Reyes, G.R. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. Virology, 2003, 310(2), 333-342.
73. Venkatachalam, T.K.; Mao, C. Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds. Bioorg. Med. Chem., 2004, 12, 4275-4284.
74. Sun, C.; Zhang, X.; Huang, H.; Zhou, P.: Synthesis and evaluation of a new series of substituted acyl(thi)ourea and thiadiazolo [2, 3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuroamidase. Bioorg. Med. Chem., 2006, 14, 8574-8581.
75. Krutosikova, A.; Kovac, J.; Sykara, V. Coll. Czech. Chem. Commun., 1994, 39, 1892.
76. For the relevance of molecular docking studies in rational antiviral design see: Drews, J. Drug discovery: a historical perspective. Science; 2000, 287, 1960-1964.
77. See for example: Mari, K.; Takigava, T.; Matsuo, T. Tetrahedron, 1979, 35, 933-940.
78. Maruyama, T.; Hanai, Y.; Sato, Y.; Snoeck, R.; Andrei, G.; Hosaya, M.; Balzarene, J.; De Clerq, E. Chem. Pharm. Bull., 1993, 41, 516-521.
79. Ikejiri, M.; Saijo, M.; Marikawa, S.; Fukushi, S.; Mizutani, T.; Kurane, I.; Maruyama, T.: Anti-SARS-Cov activity of nucleoside analogs having 6-chloropurine as a nucleobase Nucleic Acid Symposium, 2006, 50, 113-114.
80. see for example: De Clerq, E. Potential antivirals and antiviral strategies against SARS coronavirus infections. Expert Rev. Anti Infect Ther., 2006, 4, 291-302.
81. Takamatsu, S.; Maruyama, T.; Katayama, S.; Hirose, N.; Naito, M.; Izawa, K.: Synthesis of 9-(2,3-dideoxy-2-fluoro-beta-D-threopentofuranosyl) adenine (FddA) via a purine 3'-deoxynucleoside. J. Org. Chem., 2001, 66, 7469-7477.
82. Lee, Y.S.; Park, S.M.; Kim, B.H.: Synthesis of 5-isoxazol-5-yl-2 '- deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses. Bioorg. Med. Chem. Lett., 2009, 19, 1126-1128.
83. Hisaki, M.; Imabori, H.; Azuma, M.; Suzutani, T; Iwakura, F.; Onta, Y.; Kawanishi, K.; Ichigobara, Y.; Node, M.; Nishide, K.; Yoshida, I.; Ogasawara, M. Synthesis and anti-influenza virus activity of novel pyrimidine derivatives. Antiviral. Res., 1999, 42, 121-137.
84. Winkler, M.; Domarkas, J.; Schwerger, L.F.; O'Hagan, D. Angew. Chem. Int. Ed., 2008, 47, 10141-10143.
85. Brookes, S.; Bressels, P.; Ng N.F.L., Woods, C.; Bell, D.N.; Adamson, G. Bioconjug. Chem., 2006, 17, 530-537.
86. Wu, Q.; Qu, F.; Wan, J.; Zhu, X.; Xia, Y.; Peng, L. Design, synthesis, and characterization of photolabeling probes for the study of the mechanisms of the antiviral effects of ribavarin. Helvetica Chimica Acta, 2004, 87, 811-819.
87. Dorman, G.; Prestwich, G.D. Trends Biotechnol., 2000, 18, 64.
88. De Clerq, E. J. Clin. Virol., 2004, 30, 115.
89. Selvam, P.; Murugesh, N.; Chandramohan, M.; Sidwell, R.W.; Wandersce, M.K.; Smee, D.F. Chem. Chemother., 2006, 17, 269.
90. for an exaustive reference on the anti-influenza activity of arbidol see: Glushkov, R.G. Drugs Future, 1992, 17(12), 1079.
91. Zhao, Y.F.; Dong, J.H.; Gong, P. Synthesis and anti-influenza activity of ethyl 6-bromo-5-hydroxyindole-3-carboxylate derivatives. Chinese Chem. Lett., 2004, 15, 1039-1042.
92. Kai, H.; Matsumoto, H.; Takase, A.; Fujiwara, T.; Sugimoto, H. Bioorg. Med. Chem. Lett., 2001, 11, 1997.
93. for a general overview see: (a) Phuwapraisiran, P.; Matsunaga, S.; Van Soest, R.W.; Fusetani, N. J. Nat. Prod., 2002, 65, 942.
94. Zajac, M.A.; Vedejs, E. Org. Lett., 2004, 6, 597.
95. Wang, W.L.; Yao, D.Y.; Gu, M.; Fan, M.Z.; Li, J.Y.; Xing, Y.C., Nan, F.J. Synthesis and biological evaluation of novel bisheterocycle- containing compounds as potential anti-influenza virus agents Bioorg. Med. Chem. Lett., 2005, 15, 5284-5287.
96. Cheng, G.; Li, S.; Li, J.; Hu, Y. Three-component, one-pot synthesis of novel 2,4-substituted 5-azolylthiopyrimidine library for screening against anti-influenza virus A: Bioorg. Med. Chem. Lett., 2008, 18, 1177-1180.
97. Hensens, O.D.; Goetz, M.A.; Liesch, J.M.; Zink, D.L.; Helms, G.L.; Singh, S.B. Isolation and structure of flutimide, a novel endonuclease inhibitor of influenza virus. Tetrahedron Lett., 1995, 36, 2005.
98. Tomassini, E.; Singh, S.B. Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-dione, endonuclease inhibitors of influenza virus. J. Org. Chem., 2001, 66, 5504-5516.
99. Furuta, Y.; Takahashi, K.; Fukuta, Y.; Kuno, M.; Kamiyama, T.; Kozaki, K.; Nomura, N.; Egawa, H.; Minami, S.; Watanabe, Y.; Narita, H.; Shiraki, K. In vitro and in vivo activities of antiinfluenza virus compound T-705 Antimicrob. Agents Chemother., 2002, 46, 977-981.
100. Pleschka, S.; Wolff, T.; Ehrhardt, C.; Hobom, G.; Planz, O.; Rapp, U.R. Ludwig, S. Influenza virus propagation is impaired by inhibition of the RAF/MEK/ERK signaling cascade. Nat. Cell Biol., 2001, 3, 301-305.
101. Shin, Y.K.; Li, K.; Liu, Q.; Anderson, D.H.; Babiuk, L.A.; Zhou, Y. J. Virol., 2007, 81, 12730-12739.
102. Nencioni, L.; De Chiara, G.; Sgarbanti, R.; Amatore, D.; Aquilano, K.; Marcocci, M.E.; Serafino, A.; Torcia, M.; Cozzolino, F.; Ciriolo, M.R.; Garaci, E.; Palamara, A.T. Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication. J. Biol. Chem., 2009, 284 (23), 16004-16015.
103. Frémont, L. Biological effects of Resveratrol. Life Sci., 2000, 66, 663-673.
104. Sawai, R.; Kuroda, K.; Shibata, T.; Gomyou, R.; Osawa, K.; Shimizu, K. Anti-influenza virus activity of Chaenomeles sinensis. J. Ethnopharmacol., 2008, 118(1), 108-112.
105. Neumann, G.; Hughes, M.T.; Kawaoka, Y. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J., 2000, 19, 6751-6758.
106. Nencioni, L.; Sgarbanti, R.; De Chiara, G.; Garaci, E.; Palamara, A.T. Influenza virus and redox mediated cell signaling: a complex network of virus/host interaction. New Microbiol., 2007, 30(4), 367-375.
107. Garaci, E.; Palamara, A.T.; Di Francesco, P.; Favalli, C.; Ciriolo, M.R.; Rotilio, G. Glutathione inhibits replication and expression of viral proteins in cultured cells infected with Sendai virus. Biochem. Biophys. Res. Commun., 1992, 188, 1090-1096.
108. Palamara, A.T.; Perno, C.F.; Ciriolo, M.R.; Dini, L.; Balestra, E.; D'Agostini, C.; Di Francesco, P.; Favalli, C.; Rotilio, G.; Garaci, E. Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral. Res., 1995, 27 (3), 237-253.
109. Garaci, E.; Palamara, A.T.; Ciriolo, M.R.; D'Agostini, C.; Abdel-Latif, M.S.; Aquaro, S.; Lafavia, E.; Rotilio, G. Intracellular GSH content and HIV replication in human macrophages. J. Leuk. Biol., 1997, 62, 54-59.
110. Palamara, A.T.; Garaci, E.; Rotilio, G.; Ciriolo, M.R.; Casabianca, A.; Fraternale, A.; Rossi, L.; Schiavano, G.F.; Chiarantini, L.; Magnani, M. AIDS Res. Hum. Retroviruses, 1996, 12 (14), 1373-1381.
111. Nucci, C.; Palamara, A.T.; Ciriolo, M.R.; Nencioni, L.; Savini, P.; D'Agostini, C.; Rotilio, G.; Cerulli, L.; Garaci, E. Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply. Exp Eye Res., 2000, 70 (2), 215-220.
112. Choi, J.; Liu, R.M.; Kundu, R.K.; Sangiorgi, F.; Wu, W.; Maxson, R.; Forman, H.J. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J. Biol. Chem., 2000, 275(5), 3693-3698.
113. Hennet, T.; Peterhans, E.; Stocker, R. Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. J. Gen. Virol., 1992, 73(Pt 1), 39-46.
114. Mileva, M.; Tancheva, L.; Bakalova, R.; Galabov, A.; Savov, V.; Ribarov, S. Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection. Toxicol. Lett., 2000, 114 (1-3), 39-45.
115. Cai, J.; Chen, Y.; Seth, S.; Furukawa, S.; Compans, R.W. Jones, D.P. Inhibition of influenza infection by glutathione. Free Radic. Biol. Med., 2003, 34, 928-936.
116. Buffinton, G.D.; Christen, S., Peterhans, E.; Stocker, R. Oxidative stress in lungs of mice infected with influenza A virus. Free Radic. Res. Commun., 1992, 16 (2), 99-110.
117. Oda, T., Akaike, T.; Hamamoto, T.; Suzuki, F.; Hirano, T.; Maeda, H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science, 1989, 244 (4907), 974-976.
118. Suliman, H.B., Ryan, L.K.; Bishop, L.; Folz, R.J. Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. Am. J. Physiol. Lung Cell Mol. Physiol., 2001, 280 (1), L69-78.
119. Fraternale, A.; Paoletti, M.F.; Casabianca, A.; Nencioni, L.; Garaci, E.; Palamara, A.T.; Magnani, M. GSH and analogs in antiviral therapy. Mol. Aspects Med., 2009, 30 (1-2), 99-110.
120. Gao, W.Y.; Jia, W.; Li, H.B. Large Eddy Simulations of Mixing Time in a Stirred Tank. Chem. Industry Eng., 2002, 10, 1-7.
121. Wang, X.; Jia, W.; Zhao, A.; Wang, X. Anti-influenza agents from plants and traditional Chinese medicine. Phytother. Res., 2006, 20, 335-341.
122. Sokmen, M.; Angelova, M.; Krumova, E.: Protective effect of polyphenol-rich extract on acute lung injury in influenza virus infected mice. Life Sci., 2005, 76, 2981-2993.
123. Hamauzu, Y.; Yasui, H.; Inno, T. Phenolic profile, antioxidant property, and anti-influenza viral activity of Chinese quince (pseudocydonia sinensis schneid.), quince (cydonia oblonga mill.) and apple (malus domestica mill.) fruits. J. Agric. Food Chem., 2005, 53, 928-934.
124. Palamara, A.T.; Nencioni, L.; Aquilano, K.; De Chiara, G.; Hernandez, L.; Cozzolino, F.; Ciriolo, M.R.; Garaci, E.: Inhibition of Influenza A virus replication by resveratrol. J. Infect. Dis., 2005, 191, 1719-1729.
125. Venturini Moro, A.; Sega P. Cardoso, F.; Roque D.; Correia, C. Heck arylation of styrenes with arenediazonium salts: short, efficient, and stereoselective synthesis of resveratrol, DMU-212, and analogues. Tetrahedron Lett., 2008, 49, 5668-5671.
126. Andrus, B.M.; Liu, J.; Meredith, E.L.; Nartey, E. Synthesis of resveratrol using a direct decarbonylative Heck approach from resorcylic acid. Tetrahedron Lett., 2003, 44, 4819-4822.
127. Solladie', G.; Pasturel-Jacope', Y.; Maignan, J. A reinvestigation of resveratrol synthesis by Perkins reaction. Application to the synthesis of aryl cinnamic acid. Tetrahedron, 2003, 59, 3315-3321.
128. Guiso, M.; Marra, C.; Farina, A. A new efficient resveratrol synthesis. Tetrahedron Lett., 2002, 43, 597-598.
129. Fremont, L. Biological effects of resveratrol. Life Sci., 2000, 66, 663-673.
130. Gusman, J.; Malonne, H.; Atassi, G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis, 2001, 22(8), 1111-1117.
131. Wu, J.M.; Wang, Z.R.; Hsieh, T.C.; Bruder, J.L.; Zou, J.G.; Huang, Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J. Mol. Med., 2001, 8(1), 3-17.
132. Sun, A.Y.; Simonyi, A.; Sun, G.Y. The "French paradox" and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med., 2002, 32, 314-318.
133. Jang, D.S.; Kang, B.S.; Ryu, S.Y.; Chang, I.M.; Min, K.R.; Kim, Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan- induced oxygen radical production. Biochem. Pharmacol., 1999, 57, 705-712.
134. Wang, Y.; Lee, K.W.; Chan, F.L.; Chen, S.; Leung, L.K. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol. Sci., 2006, 92, 71-77.
135. Stivala, L.A.; Savio, M.; Carafoli, F.; Perucca, P.; Bianchi, L.; Maga, G.; Forti, L.; Pagnoni, U.M.; Albini, A.; Prosperi, E.; Vannini V. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem., 2001, 276, 22586-22594.
136. Dong, Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat. Res., 2003, 523, 145-150.
137. Docherty, J.J.; Smith, J.S.; Fu, M.M.; Stoner, T.; Booth, T. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. Antiviral. Res., 2004, 61, 19-26.
138. Heredia, A.; Davis, C.; Redfield, R. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J. Acquir. Immune Deficiency Syndromes, 2000, 25(3), 246-255.
139. Cros, J.; Palese, P. Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res., 2003, 95(1-2), 3-12.
140. Savouret, J.F.; Quesne, M. Resveratrol and cancer: a review. Biomed. Pharmacother., 2002, 56, 84-87.
141. Romero-Pérez, A.I.; Lamuela-Raventós, R.M.; Andrés-Lacueva, C.; de la Torre-Boronat, M.C. Method for the quantitative extraction of resveratrol and piceid isomers in grape berry skins. Effect of powdery mildew on the stilbene content. J. Agric. Food Chem., 2001, 49, 210-215.
142. For a review on the synthesis of stilbenes see: Ferré-Filmon, K.; Delaude, L.; Demonceau A.; Noels A.F. Catalytic methods for the synthesis of stilbenes with an emphasis on their phytoalexins. Coord. Chem. Rev., 2004, 248, 2323-2336.
143. Yu, J.; Gaunt, M.J.; Spencer, J.B. Convenient Preparation of trans- Arylalkenes via Palladium(II)-Catalyzed Isomerization of cis- Arylalkenes. J. Org. Chem., 2002, 67, 4627.
144. Botella, L.; Nájera, C. Synthesis of methylated resveratrol and analogues by Heck reactions in organic and aqueous solvents. Tetrahedron, 2004, 60, 5563-5570.
145. Bazin, M.A.; Kihel, L.E.; Lancelot J.C.; Rault, S. Original one-pot microwave-promoted Hunsdiecker-Suzuki strategy: straightforward access to trans-1,2-diarylethenes from cinnamic acids. Tetrahedron Lett., 2007, 48, 4347-4351.
146. Moro, A.V.; Cardoso, F.S.P.; Correia, C.R.D. Heck arylation of styrenes with arenediazonium salts: short, efficient, and stereoselective synthesis of resveratrol, DMU-212, and analogues. Tetrahedron Lett., 2008, 49, 5668.
147. Farina, A.; Ferranti, C.; Marra, C.; Guiso M.; Norcia, G. Synthesis of hydroxystilbenes and their derivatives via Heck reaction. Nat. Prod. Res., 2007, 21, 564-568.
148. Brooks, P.R.; Wirtz, M.C.; Vetelino, M.G.; Rescek, D.M.; Woodworth, G.F.; Morgan, B.P.; Coe, J.W.J. Boron trichloride/tetra-nbutylammonium iodide: A mild, selective combination reagent for the cleavage of primary alkyl aryl ethers. Org. Chem., 1999, 64, 9719.
149. Sale, S.; Tunstall, RG.; Ruparelia, K.C.; Potter, G.A.; Steward, W.P.; Gescher, A.J. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'- tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells. Int J. Cancer, 2005, 115(2),194-201.
150. Solladié, G.; Pasturel-Jacopé, Y.; Maignan J. A re-investigation of resveratrol synthesis by Perkins reaction. Application to the synthesis of aryl cinnamic acids. Tetrahedron, 2003, 59, 3315-3321.
151. Kim, H.K.; Jeon, W.K.; Ko, B.S. Flavanone glycosides from Citrus junos and their anti-influenza virus activity. Planta Med., 2001, 67, 548-549.
152. Hayashi, K.; Mori, M.; Matsutani Knox, Y.; Suzutan, T.; Ogasawara, M.; Yoshida, I.; Hosokawa, K.; Tsukui, A.; Azum, M. Anti influenza virus activity of a red-fleshed potato anthocyanin. Food Sci. Technol. Res., 2003, 9 (3), 242-244.
153. Song, J.M.; Lee, K.H.; Seong, B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res., 2005, 68(2),66-74.
154. Uesato, S.; Taniuchi, K.; Kumagai, A.; Nagaoka, Y.; Seto, R.; Hara, Y.; Tokuda, H.; Nishino, H. Inhibitory effects of 3-O-Acyl- (1)-catechins on epstein-barr virus activation. Chem. Pharm. Bull., 2003, 51(12), 1448-1450.
155. Chang, L.K.; Wei, T.T.; Chiu, Y.F.; Tung, C.P.; Chuang, J.Y.; Hung, S.K.; Li, C.; Liu, S.T. Inhibition of epstein-barr virus lytic cycle by (-)-epigallocatechin gallate. Biochem. Biophys. Res. Commun., 2003, 301, 1062-1068.
156. Fassina, G.; Buffa, A.; Benelli, R.; Varnier, O.; Noonan, D.M.; Albini, A. Polyphenolic antioxidant (-)-Epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS, 2002, 16, 939-941.
157. Nakane, H.; Ono, K. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry, 1990, 29(11), 2841-2845.
158. Nakayama, M.; Suzuki, K.; Toda, M.; Okubo, S.; Hara, Y.; Shimamura, T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral. Res., 1993, 21(4), 289-99.
159. Imanishi, N.; Tuji, Y.; Katada, Y.; Maruhashi, M.; Konosu, S.; Mantani, N.; Terasawa, K.; Ochiai, H. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol. Immunol., 2002, 46(7), 491-494.
160. Song, J.M.; Park, K.D.; Lee, K.H.; Byun, Y.H.; Park, J.H.; Kim, S.H.; Kim, J.H.; Seong, B.L. Biological evaluation of antiinfluenza viral activity of semi-synthetic catechin derivatives. Antiviral. Res., 2007, 76(2), 178-185.
161. Furuta, T.; Hirooka, Y.; Abe, A.; Sugata, Y.; Ueda, M.; Murakami, K.; Suzuki, T.; Tanaka, K.; Kan, T. Concise synthesis of dideoxyepigallocatechin gallate (DO-EGCG) and evaluation of its antiinfluenza virus activity. Bioorg. Med. Chem. Lett., 2007, 17, 3095-3098.
162. For other examples of similar ring formation see: Yao, C.F., Jang, Y.J.; Yan, M.C. An Easy and Efficient Synthesis of 3- Nitrochromans. Tetrahedron Lett., 2003, 44, 3813-3816.
163. Brenes, M.; Garcia, A.; Gracia, P.; Rios, J.J.; Garrido, A. Phenolic compounds in Spanish oils. J. Agric. Food. Chem., 1999, 47, 3535-3540.
164. Villanova, L.; Villanova, L.; Fasiello, G.; Merendino, A. Process for the recovery of tyrosol and hydroxytyrosol from oil mill wastewaters and catalytic oxidation method in order to convert tyrosol in hydroxytyrosol. Eur. Patent EP 1623960 A1, 2006.
165. Lee-Huang, S.; Huang, P.L.; Zhang, D.; Lee, J.W.; Bao, J.; Sun, Y.; Chang, Y.T.; Zhang, J.Z.H.; Huang, P.L. Discovery of smallmolecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. Integrase inhibition. Biochem. Biophys. Res. Commun., 2007, 354, 872-878.
166. Espin, J.C.; Soler-Rivas, C.; Wichers, H.J. Characterization of the total free radical scavenger capacity of vegetable oils and oil fractions using 2,2-diphenyl-1-picrylhydrazyl radical. J. Agric. Food Chem., 2000, 48, 648-656.
167. Pacheco, Y.M.; Bermúdez, B.; López, S.; Abia, R.; Villar, J.; Muriana, F.J. Minor compounds of olive oil have postprandial anti-inflammatory effects. Br. J. Nutr., 2007, 29, 1-4.
168. Furneri, P.M.; Marino, A.; Saija, A.; Uccella, N.; Bisignano G. In vitro antimycoplasmal activity of oleuropein. Int. J. Antimicrob. Agents, 2002, 20(4), 293-296.
169. Lee-Huang, S.; Huang, P.L.; Zhang, D.; Lee, J.W.; Bao, J.; Sun, Y.; Chang, Y.T.; Zhang, J.Z.H. and Huang, P.L. Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part II. Integrase inhibition. Biochem. Biophys. Res. Commun., 2007, 354, 879-884.
170. Bao, J.; Zhang, D.W.; Zhang, J.Z.H.; Lee Huang, P.; Lin Huang, P. and Lee-Huang, S.: Computational study of bindings of olive leaf extract (OLE) to HIV-1 fusion protein gp41. FEBS Lett., 2007, 581, 2737-2742.
171. Yamada, K.; Ogawa, H.; Hara, A.; Yoshida, Y.; Yonezawa, Y.; Karibe, K.; Nghia, V.B.; Yoshimura, H.; Yamamoto, Y.; Yamada, M.; Nakamura, K.; Imai, K. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus. Antiviral. Res., 2009, 83, 35-44.
172. Allouche, N.; Fki, I.; Sayadi, S. Toward a high recovery of antioxidants and purified hydroxytyrosol from olive mill wastewater. J. Agric. Food Chem., 2004, 52, 267-273.
173. Bouaziz, M.; Sayadi, S. Isolation and evaluation of antioxidants from a tunisian cultivar olive tree leale. Eur. J. Lipid Sci. Technol., 2005, 107, 497-504.
174. Espín, J.C.; Soler-Rivas, C.; Cantos, E.; Tomás-Barberán, F.A.; Wichers, H.J. Synthesis of the antioxidant hydroxytyrosol using tyrosinase as biocatalyst. J. Agric. Food Chem., 2001, 49, 1187-1193.
175. Allouche, N.; Damak, M.; Ellouz, R.; Sayadi. S. Synthesis of the Antioxidant Hydroxytyrosol by Conversion of Tyrosol Using Whole Cells of Pseudomonas aeruginosa App. Env. Microbiol., 2004, 70, 2105-2109.
176. Allouche, N.; Sayadi, S. Synthesis of Hydroxytyrosol, 2-Hydroxyphenylacetic acid and 3- Hydroxyphenylacetic acid by Differential Conversion of Tyrosol Isomers Using Serratia marcescens Strain. J. Agric. Food Chem., 2005. 53, 6525-6530.
177. Bouallagui, Z.; Sayadi, S. Production of high hydroxytyrosol yields via tyrosol conversion by Pseudomonas aeruginosa immobilizer resting cells. J. Agric. Food Chem., 2006, 54, 9906-9911.
178. Azabou, S.; Najjar, W.; Ghorbel, A.; Sayadi S. Mild Photochemical Synthesis of the Antioxidant Hydroxytyrosol via Conversion of Tyrosol. J. Agric. Food Chem., 2007, 55, 4877-4882.
179. Bernini, R.; Mincione, E.; Barontini, M.; Crisante, F. Convenient synthesis of hydroxytyrosol and its lipophilic derivatives from tyrosol or homovanillyl alcohol. J. Agric. Food Chem., 2008, 56, 8897-904.
180. Bernini, R.; Mincione, E.; Barontini, M.; Crisante, F. A novel use of the recyclable polymer-supported IBX: an efficient chemoselective and regioselective oxidation of phenolic compounds. The case of hydroxytyrosol derivatives. Tetrahedron Lett., 2009, 50(12), 1307-1310.
181. for a recent multi-steps synthesis of HT and its ester derivatives from tyrosol see also: Bovicelli, P.; Antonioletti, R.; Mancini, S.; Causio, S.; Borioni, G.; Ammendola, S.; Barontini M. Expedient Synthesis of Hydroxytyrosol and its Esters. Synthetic Commun., 2007, 37, 4245-4252.
182. Mori, H.; Sugie, S.; Rahman, W.; Suzui, N. Chemoprevention of 2- amino-1-methyl-6 phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats. Cancer Lett., 1999, 143, 195-198.
183. Lu, F.J.; Tseng, S.N.; Li, M.L.; Shih, S.R. In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid. Arch. Virol., 2002, 147, 273-84.
184. Ehrhardt, C.; Hrincius, E.R.; Korte, V.; Mazur, I.; Droebner, K.; Poetter, A.; Dreschers, S.; Schmolke, M.; Planz, O.; Ludwig S. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral. Res., 2007, 76, 38-47.
185. For the antioxidant activity of tocopherols see: Morris, M.C.; Evans, D.A.; Tangney, C.C.; Bienias, J.L.; Wilson, R.S.; Aggarwal, N.T.; Scherr, P.A. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am. J. Clin. Nutr., 2005, 81, 508-514.
186. Friel, H.; Lederman, H. A nutritional supplement formula for influenza A (H5N1) infection in humans. Med. Hypothes., 2006, 67, 578-87.
187. Mileva, M.; Tancheva, L.; Bakalova, R.; Galabov, A.; Savov, V.; Ribarov, S. Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection. Toxicol. Lett., 2000, 114 (1-3), 39-45.
188. Mileva, M.; Bakalova, R.; Tancheva, L.; Galabov, A.; Ribarov, S. Effect of vitamin E supplementation on lipid peroxidation in blood and lung of influenza virus infected mice. Comp. Immunol. Microbiol. Infect. Dis., 2002, 25 (1), 1-11.
189. Tantcheva, L.P.; Stoeva, E.S.; Galabov, A.S.; Braykova, A.A.; Savov, V.M.; Mileva, M.M. Effect of vitamin E and vitamin C combination on experimental influenza virus infection. Methods Find Exp. Clin. Pharmacol., 2003, 25 (4), 259-264.
190. Faustman, C.; Liebler, D.C.; Burr, J.A. Tocopherol oxidation in beef and in bovine muscle microsomes. J. Agric. Food Chem., 1999, 47, 1396-1399.
191. Saladino, R.; Neri, V.; Farina, A.; Crestini; C.; Nencioni, L.; Palamara, A.T. A novel and efficient synthesis of tocopheryl quinines by homogeneous and heterogeneous methyltrioxorhenium/hydrogen peroxide catalytic systems. Adv. Synth. Catal., 2008, 350, 321-331.
192. Saladino, R.; Neri, V.; Pelliccia, A. R.; Caminiti, R.; Sadun C. Preparation and structural characterization of polymer-supported methylrhenium trioxide systems as efficient and selective catalysts for the epoxidation of olefins. J. Org. Chem., 2002, 67, 1323-1332.
193. Saladino, R.; Andreoni, A.; Neri, V.; Crestini, C. A novel and efficient catalytic epoxidation of olefins and monoterpenes with microencapsulated Lewis base adducts of methyltrioxorhenium. Tetrahedron, 2005, 61, 1069-1075.
194. Bianchini, G.; Crucianelli, M.; Crestini, C.; Saladino, R. Catalytic MTO-based C-H insertion reactions of hydrogen peroxide: an investigation on the polymeric support role in heterogeneous conditions. Top. Catal., 2006, 40, 221-227.